Expression and Clinical Significance of Mucoprotein MUC5AC in Patients with Chronic Obstructive Pulmonary Disease

Lai Yi,Li Wen
DOI: https://doi.org/10.3870/j.issn.1672-0741.2009.03.027
2009-01-01
Abstract:Objective To explore the expression and clinical role of mucoprotein MUC5AC in patients with stable chronic obstructive pulmonary disease (COPD). Methods The patients were divided into three groups: COPD group, smoking control group and normal control group. Epithelial cells were isolated and cultured from the tracheal tissue of the pulmonary lobe excised during chest surgical operation. Mucoprotein MUC5AC in the supernatant was measured quantitatively by ELISA, and mucoprotein MUC5AC mRNA was detected in the cultured tracheal epithelial cells by RT-PCR. Results The expression levels of mucoprotein MUC5AC mRNA and protein in tracheal epithelial cells were low in normal control group, and those in smoking control and COPD groups were significantly higher than those in normal control group (P<0.05). At the same time, the expression levels of mucoprotein MUC5AC in COPD group were higher than those in smoking control group (P<0.05). Conclusion Smoking and COPD can obviously increase the expression levels of mucoprotein MUC5AC mRNA and protein in tracheal epithelial cells. There exists high secretion of MUC5AC in stable COPD patients, which may be an important factor during the progressive development of COPD.
What problem does this paper attempt to address?